Continuous Proteoform Process Validation for CQA Ratio Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods fail to provide tight regulatory control over proteoform and critical quality attribute (CQA) ratios in monoclonal antibody production due to environmental variables and dynamic expression, leading to unpredictable biological activity, immunogenicity, and aggregation, which are critical for process monitoring and diagnostics.
Innovation Solution
A continuous process validation system with a top-down and bottom-up analytical approach using a multi-modal four-dimensional analytical strategy, coupled with artificial intelligence, to monitor and validate proteoform biosynthesis by analyzing intact proteins and their fragments, identifying and quantifying deviations from reference points, and confirming changes through isotopic labeling and mass spectrometry.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If environmental variables and dynamic expression are monitored in monoclonal antibody production, then proteoform and CQA ratios can be controlled, but the system complexity and difficulty of monitoring increase significantly
Solution Approach 1:
The monitoring system is segmented into multiple independent detection channels, each targeting specific proteoforms or CQAs. This allows complex monitoring to be broken down into manageable modular units that can be independently optimized and controlled
Solution Approach 2:
The system implements continuous feedback loops where proteoform and CQA measurements are fed back to control environmental variables and expression conditions in real-time, enabling dynamic adjustment to maintain desired ratios despite system complexity
2Manufacturing precision
If tight regulatory control is implemented over proteoform and CQA ratios, then product quality and biological activity are improved, but the ease of manufacture and process flexibility are reduced
Solution Approach 1:
The system performs preliminary characterization and mapping of proteoform families and their environmental dependencies before production. This pre-established knowledge base enables automated control algorithms to maintain precision without requiring complex real-time manual adjustments
Solution Approach 2:
The system dynamically adjusts multiple process parameters (pH, temperature, nutrient composition, oxygen levels) in a coordinated manner to achieve desired proteoform ratios. By changing multiple parameters simultaneously rather than relying on single-factor control, the system maintains manufacturing precision while preserving operational flexibility
3Measurement precision
If comprehensive proteoform analysis is performed using top-down and bottom-up approaches, then measurement precision and detection sensitivity are improved, but analysis time and productivity are reduced
Solution Approach 1:
The analytical workflow is segmented into top-down (intact protein analysis) and bottom-up (peptide fragmentation) pathways that operate in parallel. Each pathway targets different aspects of proteoform characterization, allowing comprehensive analysis to be distributed across multiple concurrent channels rather than sequential steps
Solution Approach 2:
The system merges data from top-down and bottom-up approaches through integrated data processing and correlation algorithms. This combination enables the system to achieve high measurement precision by cross-validating results from both methodologies while maintaining high throughput through automated data fusion
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, automated, and continuous monitoring of proteoform and CQA ratios, ensuring process continuity and product quality by detecting deviations and confirming changes in proteoforms and host-cell proteins, metabolites, and nutrients, even in high-concentration environments, with high sensitivity and specificity.
Implementation Method 1
Identification of these proteins depends heavily on the use of mass spectrometry (MS) and DNA databases to predict protein sequences
Implementation Method 2
Samples of this complexity require liquid chromatographic (LC) or capillary electrophoretic (CE) separation before MS
Implementation Method 3
Samples of this complexity require liquid chromatographic (LC) or capillary electrophoretic (CE) separation before MS
Implementation Method 4
Still another level of discrimination is achieved in the MS by fragmentation of molecular ions and separation of the resulting unique fragment ions according to their mass
Implementation Method 5
confirming changes through isotopic labeling and mass spectrometry
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A system and method is provided for validating the manufacturing process for the production of complex biological compositions, and particularly for providing process validation information for evaluation by a federal regulatory agency. The system and method continuously and chronologically assess the concentration of proteoforms within the biological composition as it is being produced in a fermentor. Samples from the fermentor are analyzed in a pre-selected array of analysis columns, with data generated by the columns being accumulated and evaluated, and particularly compared with data from previous stages in the production process. A continuous process validation system includes top-down and bottom-up analysis sectors, each including a plurality of different analysis columns that can be selected by the controller for a particular biological composition and a particular production process.